Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic inflammation
Biotech
MyMD's drug shows promise against age-related inflammation
MyMD’s lead asset has hit both primary endpoints in a mid-phase study of age-related inflammation, setting the company up for phase 3 talks with FDA.
James Waldron
Jul 31, 2023 11:07am
Washing out WASH protein complex drives inflammation in mice
Sep 26, 2022 10:10am
Vasella helps Numab to CHF22M round ahead of cancer trial start
Mar 9, 2020 7:00am
Nodthera nets $40M to take on chronic inflammation
Jun 25, 2018 2:00am
SetPoint Medical nabs $30M for bioelectronics rheumatoid arthritis trial
Aug 28, 2017 9:36am
Novartis VC fund coleads $17M Series A in inflammatory disease startup
Sep 12, 2016 7:00am
